Literature DB >> 21839739

Advanced flowcytometric analysis of regulatory T cells: CD127 downregulation early post stem cell transplantation and altered Treg/CD3(+)CD4(+)-ratio in severe GvHD or relapse.

Melanie Bremm1, Sabine Huenecke, Thomas Lehrnbecher, Eva Ponstingl, Regine Mueller, Annekathrin Heinze, Gesine Bug, Andrea Quaiser, Michael Kapinsky, Claudia Brehm, Peter Bader, Gisbert Schneider, Thomas Klingebiel, Ulrike Koehl.   

Abstract

Regulatory T cells (Tregs) are of crucial importance to suppress graft versus host disease (GvHD) post allogeneic stem cell transplantation (SCT), but are also known to impair antitumor immunity. However, Treg longitudinal studies are rare and in this respect advanced flowcytometric approaches for Treg characterization are necessary. To investigate the relation of both the percentage and the absolute numbers of Tregs on GvHD or relapse we measured CD4(+)CD25(+/hi)CD127(lo/-) Tregs in 239 peripheral blood (PB) samples of 16 patients during the first two years post-SCT. A 10-color flowcytometric panel was established to evaluate Treg subpopulations and has been tested in ten healthy individuals. In patients we demonstrated a decrease in CD127 expression on T cells early post-SCT which increases during the first year. Moreover, Tregs reached higher absolute numbers in patients with GvHD≤grade I compared to those with GvHD grades II-IV. In contrast, the percentage of Tregs was significantly higher in patients with GvHD grades II-IV or disease relapse compared to those without GvHD. These patients fit into the range of healthy individuals where a median value of 7.5% and 6.4% of T helper cells were characterized as CD4(+)CD25(+/hi)CD127(lo/-) and CD4(+)CD25(+/hi) Tregs, respectively. Furthermore, Tregs could be further subdivided into 40% naïve, 51% central memory and 9% effector memory Tregs. Our results showed for the first time a downregulation of CD127 expression on T cells including Tregs in patients early post-SCT. Additionally, new insights into the recovery of Tregs regarding GvHD and relapse were provided.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21839739     DOI: 10.1016/j.jim.2011.07.018

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  7 in total

Review 1.  Notch Signaling and Alloreactivity.

Authors:  Vedran Radojcic; Ivan Maillard
Journal:  Transplantation       Date:  2016-12       Impact factor: 4.939

2.  The role of regulatory T cells in the biology of graft versus host disease.

Authors:  Amy J Beres; William R Drobyski
Journal:  Front Immunol       Date:  2013-06-24       Impact factor: 7.561

3.  Regulatory CD4+CD25+ T Cells Dampen Inflammatory Disease in Murine Mycoplasma Pneumonia and Promote IL-17 and IFN-γ Responses.

Authors:  Adam N Odeh; Jerry W Simecka
Journal:  PLoS One       Date:  2016-05-13       Impact factor: 3.240

4.  Sequential monitoring of lymphocyte subsets and of T-and-B cell neogenesis indexes to identify time-varying immunologic profiles in relation to graft-versus-host disease and relapse after allogeneic stem cell transplantation.

Authors:  Cristina Skert; Simone Perucca; Marco Chiarini; Viviana Giustini; Alessandra Sottini; Claudia Ghidini; Stefano Martellos; Federica Cattina; Benedetta Rambaldi; Valeria Cancelli; Michele Malagola; Alessandro Turra; Nicola Polverelli; Simona Bernardi; Luisa Imberti; Domenico Russo
Journal:  PLoS One       Date:  2017-04-11       Impact factor: 3.240

5.  Mobilized Multipotent Hematopoietic Progenitors Promote Expansion and Survival of Allogeneic Tregs and Protect Against Graft Versus Host Disease.

Authors:  Maud D'Aveni; Anne-Béatrice Notarantonio; Viviane A Agbogan; Allan Bertrand; Guillemette Fouquet; Pauline Gastineau; Meriem Garfa-Traoré; Marcelo De Carvalho; Olivier Hermine; Marie-Thérèse Rubio; Flora Zavala
Journal:  Front Immunol       Date:  2021-02-12       Impact factor: 7.561

6.  Cyclosporine A but Not Corticosteroids Support Efficacy of Ex Vivo Expanded, Adoptively Transferred Human Tregs in GvHD.

Authors:  Sybille Landwehr-Kenzel; Anne Zobel; Isabela Schmitt-Knosalla; Anne Forke; Henrike Hoffmann; Michael Schmueck-Henneresse; Robert Klopfleisch; Hans-Dieter Volk; Petra Reinke
Journal:  Front Immunol       Date:  2021-10-11       Impact factor: 7.561

7.  Loss of Lkb1 impairs Treg function and stability to aggravate graft-versus-host disease after bone marrow transplantation.

Authors:  Xiuhua Su; Qianqian Wang; Wei Guo; Xiaolei Pei; Qing Niu; Maolan Liu; Yuanyuan Liu; Song Chen; Sizhou Feng; Yi He; Donglin Yang; Rongli Zhang; Qiaoling Ma; Weihua Zhai; Aiming Pang; Jialin Wei; Yong Huang; Yuechen Luo; Mingzhe Han; Xiaoming Feng; Erlie Jiang
Journal:  Cell Mol Immunol       Date:  2019-10-29       Impact factor: 11.530

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.